Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
3.520
+0.200 (6.02%)
Mar 9, 2026, 3:28 PM EDT - Market open
Precigen Employees
Precigen had 143 employees as of December 31, 2024. The number of employees decreased by 59 or -29.21% compared to the previous year.
Employees
143
Change (1Y)
-59
Growth (1Y)
-29.21%
Revenue / Employee
$44,119
Profits / Employee
-$2,978,084
Market Cap
1.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 596 |
| Pharming Group | 404 |
| EyePoint | 165 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
| Inventiva | 84 |
| Taysha Gene Therapies | 73 |
| Savara | 59 |
PGEN News
- 26 days ago - Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech - Seeking Alpha
- 6 weeks ago - New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis - PRNewsWire
- 7 weeks ago - Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Precigen Is Still A Buy After The Papzimeos Rally - Seeking Alpha
- 4 months ago - Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PRNewsWire